Pharmaceutical Product Liability / Eosinophilia-Myalgia Syndrome

Posted in on September 4, 2017 - Confidential

Rainwater v. Showa Denko, Inc., et al., United States District Court, Northern District of Georgia, Atlanta Division. Pharmaceutical product liability case against major Japanese pharmaceutical company. Client became seriously ill after taking contaminated tablets of L-Tryptophan, a substance classified by the FDA as a food but marketed and sold in the U.S. for its medicinal qualities. Plaintiff suffered EMS (Eosinophilia-Myalgia Syndrome), an inflammatory condition which affects the connective and muscle tissue causing extreme pain, physical debilitation, nerve degeneration, and in some cases, death. Plaintiff has severe EMS which will affect her for the remainder of her life. Amount of settlement is confidential at defendant’s request.

COVID-19 Update: Lawyers and staff are working both remotely and in the office to provide the best legal representation to our clients. If you need assistance, please call or contact us. We can do consultations over the phone or on a video conference. For referring attorneys, we’re still open for business and want to discuss partnering with you on your cases.